<VariationArchive RecordType="classified" VariationID="6618" VariationName="NM_003630.3(PEX3):c.543dup (p.Val182fs)" VariationType="Duplication" Accession="VCV000006618" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-10-30" DateCreated="2017-02-16" MostRecentSubmission="2017-02-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21657" VariationID="6618">
      <GeneList>
        <Gene Symbol="PEX3" FullName="peroxisomal biogenesis factor 3" GeneID="8504" HGNC_ID="HGNC:8858" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q24.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="143450805" stop="143490616" display_start="143450805" display_stop="143490616" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="143771917" stop="143811752" display_start="143771917" display_stop="143811752" Strand="+" />
          </Location>
          <OMIM>603164</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003630.3(PEX3):c.543dup (p.Val182fs)</Name>
      <CanonicalSPDI>NC_000006.12:143471575:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6q24.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="143471575" stop="143471576" display_start="143471575" display_stop="143471576" variantLength="1" positionVCF="143471575" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="143792712" stop="143792713" display_start="143792712" display_stop="143792713" variantLength="1" positionVCF="143792712" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>V182fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.143792713dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.143792713dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.143471576dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.143471576dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008459.1" sequenceAccession="NG_008459" sequenceVersion="1" change="g.25796dup">
            <Expression>NG_008459.1:g.25796dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003630.3" sequenceAccession="NM_003630" sequenceVersion="3" change="c.543dup" MANESelect="true">
            <Expression>NM_003630.3:c.543dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003621.1" sequenceAccession="NP_003621" sequenceVersion="1" change="p.Val182fs">
            <Expression>NP_003621.1:p.Val182fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="603164.0001" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003630.3(PEX3):c.543dup (p.Val182fs) AND Peroxisome biogenesis disorder 10A (Zellweger)" Accession="RCV000006997" Version="3">
        <ClassifiedConditionList TraitSetID="8965">
          <ClassifiedCondition DB="MedGen" ID="C3553999">Peroxisome biogenesis disorder 10A (Zellweger)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2000-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2000-10-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-02-16" MostRecentSubmission="2017-02-16">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10942428</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7562283</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10958759</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8965" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17441" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 10A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 10A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0013948" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBD10A</ElementValue>
                <XRef ID="GTR000522753" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="614882" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).
For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.
Individuals with PBDs of complementation group 12 (CG12, equivalent to CGG) have mutations in the PEX3 gene. For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614882" DB="OMIM" />
              </AttributeSet>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C3553999" DB="MedGen" />
              <XRef ID="MONDO:0013948" DB="MONDO" />
              <XRef Type="MIM" ID="614882" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="27193" SubmissionDate="2017-02-13" DateLastUpdated="2017-02-16" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603164.0001_PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER)" title="PEX3, 1-BP INS, 543T_PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER)" />
        <ClinVarAccession Accession="SCV000027193" DateUpdated="2017-02-16" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2000-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient (patient 1, PBDG-01) with Zellweger syndrome of complementation group G (PBD10A; 614882), Muntau et al. (2000) found homozygosity for a 1-bp insertion, a thymine in exon 7, at nucleotide 543 of the coding region. This frameshift mutation was predicted to result in a truncation of the C-terminal 190 amino acids of the protein. Muntau et al. (2000) noted that the patient showed marked muscular hypotonia at birth. Dysmorphic features included hypertelorism, prominent epicanthic folds, and a high, broad forehead with round face. Seizures developed on day 1 but were controlled with treatment. His condition deteriorated rapidly, with death at age 4 months.</Attribute>
              <Citation>
                <ID Source="PubMed">10958759</ID>
              </Citation>
              <XRef DB="OMIM" ID="614882" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Shimozawa et al. (2000) studied the same patient (G-01) and described the mutation as a homozygous 1-bp insertion at nucleotide 544 at the first position of codon val182, resulting in a change of codon (182-183) and introduction of a termination in codon 184.</Attribute>
              <Citation>
                <ID Source="PubMed">10942428</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Poulos et al. (1995) originally studied this patient (patient 1) and described clinical, pathologic, and biochemical findings.</Attribute>
              <Citation>
                <ID Source="PubMed">7562283</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX3" />
          </GeneList>
          <Name>PEX3, 1-BP INS, 543T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 543T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603164.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="27193" TraitType="Disease" MappingType="Name" MappingValue="PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER)" MappingRef="Preferred">
        <MedGen CUI="C3553999" Name="Peroxisome biogenesis disorder 10A (Zellweger)" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

